Aptivus

Lea en español

AptivusAptivus is the brand name for Tipranavir, or Tipranavir Disodium, manufactured and marketed by Boehringer-Ingelheim, and used in conjunction with other medications to treat HIV, or human immunodeficiency virus. The drug was first approved by the U.S. Food and Drug Administration (FDA) in 2005.
Tipranavir has been tied to a number of adverse health consequences, from bleeding in the brain and hepatitis to high blood sugar and diabetes. It has also been shown in clinical trials to increase cholesterol levels, as well as triglycerides.
To learn about your rights if you have experienced side effects after using Aptivus, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.

Defective Drugs & Medical Devices Topics

Latest Articles

Happy 4th of July

Our country is not the only thing to which we owe our allegiance. It is also owed to justice and to…

02 Jul 2020, Thursday

Supreme Court Issues Landmark LGBT Employment Law Ruling

Decision Applies Civil Rights Act to Employment Issues in All 50 States The United States Supreme Co…

25 Jun 2020, Thursday

President Seeks to Limit Liability of Meat Companies for COVID-19

Industry Continues to Be Hotspot for COVID Infection State health officials in Idaho announced on Tu…

09 Jun 2020, Tuesday